Validation of ultrasound bioimaging to predict worm burden and treatment efficacy in preclinical filariasis drug screening models
Filariasis is a global health problem targeted for elimination. Curative drugs (macrofilaricides) are required to accelerate elimination. Candidate macrofilaricides require testing in preclinical models of filariasis. The incidence of infection failures and high intra-group variation means that larg...
Main Authors: | Marriott, A, Sjoberg, H, Tyrer, H, Gamble, J, Murphy, E, Archer, J, Steven, A, Taylor, M, Turner, J |
---|---|
Format: | Journal article |
Published: |
Nature Publishing Group
2018
|
Similar Items
-
Short-course, high-dose rifampicin achieves wolbachia depletion predictive of curative outcomes in preclinical models of lymphatic filariasis and onchocerciasis
by: Aljayyoussi, G, et al.
Published: (2017) -
Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis
by: Taylor, MJ, et al.
Published: (2019) -
A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis
by: Alice Halliday, et al.
Published: (2014-10-01) -
FAIR High Content Screening in Bioimaging
by: Rohola Hosseini, et al.
Published: (2023-07-01) -
The health and economic burden of lymphatic filariasis prior to mass drug administration programmes
by: Mathew, C, et al.
Published: (2019)